Brain inflammation may be to blame for severe Parkinson's

In a study of 87 Parkinson's patients between 2008 and 2012, the degree of neuroinflammation was significantly associated with more severe depression, fatigue and cognitive impairment even after taking into consideration other factors, such as age, gender and disease duration. Researchers believe that inflammation could act as a biomarker for the disease and that reversing inflammation in the fluid surrounding the brain's cortex could help alleviate some symptoms of Parkinson's. Release

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.